Michael Sperling on Muck Rack

Michael Sperling

New York, United States
As seen in: TODAY, Color Research & Application, Nature, Wiley Online Library, MDPI, Taylor & Francis Online, JAMA (The Journal of the American Medical Association), Science Magazine, Royal Society of Chemistry, Cell Press, Healthcare IT News and
it's not going to happen - Julia Louis Dreyfus
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Thalamic organization differentially contributes to clinical conditions in epilepsy

|
By Qirui Zhang, Sam S. Javidi, Ankeeta Ankeeta, Michael Sperling, Zhiqiang Zhang, Joseph Tracy
| Nature
Abstract The thalamus plays an important role in key clinical conditions of focal temporal lobe epilepsy (TLE), but no investigation has examined whether the same thalamic local and connectome properties shape a patient’s status across these different conditions.
Open in Who Shared Issue with article?

NeuroVoices: Christina Briscoe, MD; Emily Spelbrink, MD, PhD, on Addressing Equity Gaps in Infantile Epileptic Spasms Syndrome

|
By Bruce J Brew, Isabella Ciccone, Louie Pasculli, Michael Sperling
| NeurologyLive
Infantile epileptic spasms syndrome (IESS) remains one of the most urgent and high stakes diagnoses in pediatric neurology, where early recognition and prompt initiation of evidence-based therapy can dramatically influence long term developmental outcomes. Despite well-established first line treatments such as hormonal therapy and vigabatrin, delays in diagnosis, referral, and treatment remain common, particularly among historically marginalized populations.
Open in Who Shared Issue with article?

Fenfluramine’s Safety Profile Consistent in Long-Term Extension Dravet and Lennox-Gastaut Syndrome Studies

|
By Bruce J Brew, Isabella Ciccone, Louie Pasculli, Michael Sperling
| NeurologyLive
Final results from a combined open-label extension (OLE) study (NCT03936777) indicated that long-term treatment with fenfluramine (Fintepla; UCB) in pediatric and adult patients with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) was safe and consistent with prior studies.
Open in Who Shared Issue with article?
See all 61 licensed articles (62 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified